Rethinking the immunotherapy numbers game

Immunotherapies are a major breakthrough in oncology, yielding unprecedented response rates for some cancers. Especially in combination with conventional treatments or targeted agents, immunotherapeutics offer invaluable tools to improve outcomes for many patients. However, why not all patients have...

Descripción completa

Detalles Bibliográficos
Autores principales: Bekker, Rebecca A, Zahid, Mohammad U, Binning, Jennifer M, Spring, Bryan Q, Hwu, Patrick, Pilon-Thomas, Shari, Enderling, Heiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Hypothesis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9260835/
https://www.ncbi.nlm.nih.gov/pubmed/35793871
http://dx.doi.org/10.1136/jitc-2022-005107

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9260835/
https://www.ncbi.nlm.nih.gov/pubmed/35793871
http://dx.doi.org/10.1136/jitc-2022-005107

Ejemplares similares